Low platelet counts are one facet of ITP, but when we look at it from another angle, we see the multiple dimensions of ITP. ITP is a condition of complex immune dysregulation that reduces platelet counts—causing bleeding, bruising, fatigue, and other health-related quality-of-life (HRQoL) issues—while increasing inflammation and the risk of thromboembolic events (TEs).1-5
Patients reported significant quality of life (QoL) challenges related to their ITP1
For ITP patients, several scales are available to measure and track fatigue and its impact on quality of life. These tools can help patients and healthcare providers gauge symptoms and adjust their ITP treatment accordingly.1-4
Complex immune dysregulation can lead to autoimmunity and inflammation1-6
MAT-BE-2501247 v1.0-12-2025
Vous êtes sur le point de quitter campus.sanofi/be. Sanofi n'est pas responsable du contenu de ce site externe.

Sanofi met a votre disposition, sur un portail unique dédié aux professionnels de santé, des contenus exclusifs comprenant des contenus scientifiques et des outils pour votre pratique quotidienne.